Cronos Australia Ltd
ASX:CAU

Watchlist Manager
Cronos Australia Ltd Logo
Cronos Australia Ltd
ASX:CAU
Watchlist
Price: 0.36 AUD 1.41% Market Closed
Market Cap: 199.7m AUD
Have any thoughts about
Cronos Australia Ltd?
Write Note

Profitability Summary

Cronos Australia Ltd's profitability score is 68/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

68/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

68/100
Profitability
Score
68/100
Profitability
Score
High Profitability Stocks
Health Care Industry

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
Cronos Australia Ltd

Revenue
117.3m AUD
Cost of Revenue
-76.8m AUD
Gross Profit
40.5m AUD
Operating Expenses
-20.3m AUD
Operating Income
20.3m AUD
Other Expenses
-6.5m AUD
Net Income
13.8m AUD

Margins Comparison
Cronos Australia Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
AU
Cronos Australia Ltd
ASX:CAU
200.4m AUD
35%
17%
12%
US
Mckesson Corp
NYSE:MCK
77.5B USD
4%
1%
1%
US
Amerisourcebergen Corp
LSE:0HF3
48.5B USD
3%
1%
1%
US
Cencora Inc
NYSE:COR
48B USD
3%
1%
1%
US
Cardinal Health Inc
NYSE:CAH
29.4B USD
3%
1%
1%
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW
30%
9%
7%
CN
Huadong Medicine Co Ltd
SZSE:000963
61.8B CNY
32%
9%
8%
US
Henry Schein Inc
NASDAQ:HSIC
8.3B USD
32%
5%
3%
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
60.1B CNY
11%
3%
2%
CN
Sinopharm Group Co Ltd
HKEX:1099
63.3B HKD
8%
4%
1%
IT
Amplifon SpA
MIL:AMP
5.4B EUR
25%
13%
7%
Country AU
Market Cap 200.4m AUD
Gross Margin
35%
Operating Margin
17%
Net Margin
12%
Country US
Market Cap 77.5B USD
Gross Margin
4%
Operating Margin
1%
Net Margin
1%
Country US
Market Cap 48.5B USD
Gross Margin
3%
Operating Margin
1%
Net Margin
1%
Country US
Market Cap 48B USD
Gross Margin
3%
Operating Margin
1%
Net Margin
1%
Country US
Market Cap 29.4B USD
Gross Margin
3%
Operating Margin
1%
Net Margin
1%
Country KR
Market Cap 12.2T KRW
Gross Margin
30%
Operating Margin
9%
Net Margin
7%
Country CN
Market Cap 61.8B CNY
Gross Margin
32%
Operating Margin
9%
Net Margin
8%
Country US
Market Cap 8.3B USD
Gross Margin
32%
Operating Margin
5%
Net Margin
3%
Country CN
Market Cap 60.1B CNY
Gross Margin
11%
Operating Margin
3%
Net Margin
2%
Country CN
Market Cap 63.3B HKD
Gross Margin
8%
Operating Margin
4%
Net Margin
1%
Country IT
Market Cap 5.4B EUR
Gross Margin
25%
Operating Margin
13%
Net Margin
7%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
Cronos Australia Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
AU
Cronos Australia Ltd
ASX:CAU
200.4m AUD
45%
31%
61%
79%
US
Mckesson Corp
NYSE:MCK
77.5B USD
-105%
4%
27%
18%
US
Amerisourcebergen Corp
LSE:0HF3
48.5B USD
231%
2%
24%
18%
US
Cencora Inc
NYSE:COR
48B USD
231%
2%
24%
18%
US
Cardinal Health Inc
NYSE:CAH
29.4B USD
-37%
3%
26%
17%
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW
7%
3%
9%
5%
CN
Huadong Medicine Co Ltd
SZSE:000963
61.8B CNY
15%
9%
17%
13%
US
Henry Schein Inc
NASDAQ:HSIC
8.3B USD
9%
3%
8%
5%
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
60.1B CNY
6%
2%
10%
5%
CN
Sinopharm Group Co Ltd
HKEX:1099
63.3B HKD
12%
2%
15%
7%
IT
Amplifon SpA
MIL:AMP
5.4B EUR
15%
4%
12%
7%
Country AU
Market Cap 200.4m AUD
ROE
45%
ROA
31%
ROCE
61%
ROIC
79%
Country US
Market Cap 77.5B USD
ROE
-105%
ROA
4%
ROCE
27%
ROIC
18%
Country US
Market Cap 48.5B USD
ROE
231%
ROA
2%
ROCE
24%
ROIC
18%
Country US
Market Cap 48B USD
ROE
231%
ROA
2%
ROCE
24%
ROIC
18%
Country US
Market Cap 29.4B USD
ROE
-37%
ROA
3%
ROCE
26%
ROIC
17%
Country KR
Market Cap 12.2T KRW
ROE
7%
ROA
3%
ROCE
9%
ROIC
5%
Country CN
Market Cap 61.8B CNY
ROE
15%
ROA
9%
ROCE
17%
ROIC
13%
Country US
Market Cap 8.3B USD
ROE
9%
ROA
3%
ROCE
8%
ROIC
5%
Country CN
Market Cap 60.1B CNY
ROE
6%
ROA
2%
ROCE
10%
ROIC
5%
Country CN
Market Cap 63.3B HKD
ROE
12%
ROA
2%
ROCE
15%
ROIC
7%
Country IT
Market Cap 5.4B EUR
ROE
15%
ROA
4%
ROCE
12%
ROIC
7%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More
Back to Top